Recent studies have found that inhibitors of LDH, MCT, and MPC can serve as radiosensitizers in models of glioblastoma, pancreatic cancer, SCLC and cervical cancer (11, 39, 76, 82). Here, SLC16A1 is linked to pancreatic neoplasm.